Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target?
Eva M. Lonn Salim Yusuf; José Antonio Marin Neto; HOPE-3 Trial (Heart Outcomes Evaluation-3)
Circulation Philadelphia v. 134, n. 18, p. 1311-1313, 2016Philadelphia 2016
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 2859218 Estantes Deslizantes )(Acessar)